Why would a doctor choose immunotherapy over chemotherapy?

Doctors choose immunotherapy over chemotherapy for its potential for longer-lasting effects, ability to target cancer cells specifically (fewer harsh side effects like hair loss), and when chemotherapy fails, aiming for a better quality of life and durable remission by training the immune system with "memory" to fight cancer long-term, though it can take longer to show results and isn't effective for everyone, notes Cancer Research Institute, Regional Cancer Care Associates, Comprehensive Hematology Oncology, Cancer Center, Mesothelioma Hope, Mesothelioma Center, and UT Health San Antonio MD Anderson Cancer Center.

Why immunotherapy instead of chemotherapy?

The primary distinction between immunotherapy and chemotherapy lies in how they target cancer cells and their mechanisms of action. Immunotherapy doesn't target cancer cells directly. Instead, it stimulates the immune system to recognize and combat cancer cells more effectively.

At what stage of cancer is immunotherapy used?

Immunotherapy is used across many cancer stages, from early-stage cancers (like Stage IB+ lung cancer) to prevent recurrence, to locally advanced (Stage 3) and advanced metastatic (Stage 4) cancers where it helps the immune system fight cancer that has spread, often used alone or with chemotherapy. While effective for advanced cancers like melanoma and lung cancer, its use is expanding as a first-line treatment or adjuvant therapy for various cancers, depending on specific tumor features. 

What is the success rate of immunotherapy vs chemotherapy?

The one-year survival rates further illustrate this difference: 71.96% for MSS patients on immunotherapy and 76.78% for those on chemotherapy, compared to 76.55% and 69.91% for MSI-H patients, respectively.

Is immunotherapy the last resort for cancer?

It's often used as a last resort, once other therapies have reached the end of their effectiveness.

Chemotherapy and immunotherapy: to combine or not to combine?

Which cancers are most successfully treated with immunotherapy?

Cancers with high genetic instability, like melanoma, lung cancer, kidney cancer, and bladder cancer, respond exceptionally well to immunotherapy, along with certain lymphomas and MSI-high colorectal cancers, because their numerous mutations make them "foreign" to the immune system, allowing treatments like checkpoint inhibitors to effectively unleash immune cells to attack them. Tumors linked to viruses, such as liver cancer, also show good responses due to viral proteins acting as warning signals. 

What is life expectancy after immunotherapy?

Life expectancy after immunotherapy varies greatly but has significantly improved for many, with some patients achieving long-term remission or even a "cure," while others see limited benefit, depending on cancer type, stage, and individual response, but studies show benefits can last years after treatment stops. For advanced lung cancer, median survival can range from under a year to over 18 months with immunotherapy, and some patients experience durable, years-long control, with 5-year survival rates showing improvement. 

What is the downside of immunotherapy?

Immunotherapy's disadvantages include significant immune-related side effects, like inflammation in organs (lungs, liver, colon) leading to symptoms such as fatigue, rashes, diarrhea, or more severe issues like autoimmune conditions. Other drawbacks involve high costs, the potential for long-term organ damage (requiring lifelong hormone therapy), "infusion reactions," and that it doesn't work for everyone, sometimes causing cancer progression or only partial response.
 

What new cancer drug has a 100% success rate?

There isn't one single cancer drug with a universal 100% success rate, but dostarlimab (Jemperli) showed an unprecedented 100% complete remission rate in a small, specific trial for rectal cancer patients with a particular genetic makeup (mismatch repair-deficient, or MMRd). This immunotherapy works by unleashing the immune system, allowing it to eliminate tumors without chemotherapy or radiation, offering immense hope for this niche group, but it's not a cure-all for all cancers.
 

Which cancer is most likely to metastasize?

Some of the most common types include metastatic:

• Breast cancer.
• Colorectal cancer.
• Esophageal cancer.
• Lung cancer.
• Ovarian cancer.
• Pancreatic cancer.
• Prostate cancer.
• Skin cancers.

Who is not a good candidate for immunotherapy?

Those with pre-existing conditions might not be able to pursue immunotherapy as a cancer treatment avenue. Specifically, patients with an autoimmune disease or an otherwise suppressed immune system are not always viable candidates for immunotherapy or clinical trials.

Does immunotherapy stop cancer from spreading?

Sometimes cancer cells develop ways to evade and escape the immune system, which allows them to continue to grow and metastasize, or spread to other organs. Therefore, immunotherapies are designed to boost or enhance the cancer-fighting capabilities of immune cells and tip the scales in the immune system's favor.

What qualifies you for immunotherapy?

Your eligibility for immunotherapy depends on your individual circumstances, including the type and stage of your cancer, your overall health, and whether you've previously been treated for cancer. Immunotherapy is most often used for advanced cancers or when other treatments have failed.

Do you lose your hair on immunotherapy?

Unlike chemotherapy, immunotherapy very rarely causes hair loss. However, patients receiving Atezolizumab for immunotherapy treatment can sometimes experience hair loss and thinning.

How many oncologists would refuse chemotherapy?

In keeping with a conservative ASCO position statement, 70% of oncologists said they would not generally recommend adjuvant chemotherapy for this patient, though fewer (53%) said they would decline it for themselves (P < .

Why would a doctor recommend immunotherapy?

Immunotherapy is often used in advanced stages of cancer where other treatments have been unsuccessful. The cancer cells can sometimes outsmart the immune system by making substances to turn off or help them hide from the body's immune response.

What is the $30,000 cancer pill?

A "30,000 cancer pill" likely refers to the highly expensive, monthly cost of certain chemotherapy drugs, notably Folotyn (pralatrexate) approved around 2009 for rare T-cell lymphoma, sparking debate over unsustainable cancer drug pricing despite limited survival benefits, with costs reaching hundreds of thousands annually for short-term treatments. While prices fluctuate and newer drugs emerge (like Revlimid at high costs), the $30k/month figure highlights a broader issue of exorbitant pricing for life-saving treatments, even for rare cancers. 

What is the miracle drug that melts cancer?

Dostarlimab is a form of immunotherapy, a targeted treatment which helps the immune system destroy the cancer. A clinical trial in the USA is focusing on a group of rectal cancer patients who all have mutations – or changes – to specific genes called mismatch repair (MMR) genes, which usually help repair DNA.

What is the major cancer breakthrough in 2025?

In 2025, the FDA also approved the first-ever therapy for recurrent diffuse midline glioma (DMG) with an H3 K27M mutation, which is a very rare but aggressive type of pediatric brain cancer in which most patients only live 11 to 15 months after diagnosis.

Why is immunotherapy not recommended?

Despite the success of cancer immunotherapy in demonstrating efficacy across multiple cancer types, it has also been implicated in accelerating disease progression, a concept known as HPD. Notably, this is not as common with other cancer therapeutics (118,119).

What are good signs immunotherapy is working?

Signs immunotherapy is working include tumor shrinkage or stabilization on scans, improved cancer-related symptoms, and decreasing tumor markers, often monitored by your doctor through imaging (CT, MRI, PET), blood tests, and physical exams, though side effects like inflammation can sometimes indicate activity but aren't the sole predictor of success. 

Can tumors grow during immunotherapy?

In a variety of immunotherapies, however, an unexpected acceleration of tumor growth, known as HPD, is observed in approximately 30% of patients after immune checkpoint inhibitor (ICI) treatment. HPD has a deleterious survival effect on patients and represents an urgent issue for both clinicians and patients.

What stage of cancer do they use immunotherapy?

Immunotherapy is used across many cancer stages, from early-stage cancers (like Stage IB+ lung cancer) to prevent recurrence, to locally advanced (Stage 3) and advanced metastatic (Stage 4) cancers where it helps the immune system fight cancer that has spread, often used alone or with chemotherapy. While effective for advanced cancers like melanoma and lung cancer, its use is expanding as a first-line treatment or adjuvant therapy for various cancers, depending on specific tumor features. 

When is a cancer patient considered a survivor?

You are considered a cancer survivor from the moment of diagnosis through the rest of your life, a broad definition used by major health organizations to include anyone living with, through, or beyond cancer, including family and caregivers. While some prefer to identify as survivors only after treatment ends or when cancer-free, the official view covers all stages, from active treatment to managing long-term effects or living with cancer as a chronic condition, recognizing that survivorship encompasses diverse experiences. 

Which cancers are not curable?

Incurable cancers are those that cannot be completely eliminated by current treatments, often because they've spread (metastatic) or are advanced, but they are still treatable to slow growth, manage symptoms, and extend life, with many cancers like pancreatic, liver, lung, and some brain cancers often falling into this category, though treatment advances offer hope even in incurable cases. The focus shifts to palliative and supportive care to improve quality of life, alongside therapies like chemo, radiation, or surgery to control the disease.